EASL clinical practice guidelines: liver transplantation, J Hepatol, vol.64, pp.433-85, 2016. ,
, ELTR report
, Clinical Practice EASL Guidelines on the management of acute (fulminant) liver failure, J Hepatol, vol.66, pp.1047-81, 2017.
Model for end-stage liver disease (MELD) and allocation of donor livers, Gastroenterology, vol.124, issue.1, pp.91-97, 2003. ,
DOI : 10.1053/gast.2003.50016
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List, New England Journal of Medicine, vol.359, issue.10, pp.1018-1044, 2008. ,
DOI : 10.1056/NEJMoa0801209
A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation, Gastroenterology, vol.140, issue.7, pp.1952-60, 2011. ,
DOI : 10.1053/j.gastro.2011.02.017
Excess mortality on the liver transplant waiting list: Unintended policy consequences and model for End-Stage Liver Disease (MELD) inflation, Hepatology, vol.13, issue.Suppl 1, pp.285-91, 2015. ,
DOI : 10.1002/lt.21155
Liver Transplantation in Highest Acuity Recipients, Annals of Surgery, vol.259, issue.6, pp.1186-94, 2014. ,
DOI : 10.1097/SLA.0000000000000265
Early Liver Transplantation for Severe Alcoholic Hepatitis, New England Journal of Medicine, vol.365, issue.19, pp.1790-800, 2011. ,
DOI : 10.1056/NEJMoa1105703
Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis, Hepatology, vol.38, issue.Suppl 2, pp.243-52, 2015. ,
DOI : 10.1097/CCM.0b013e3181e71530
End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates, Hepatology, vol.45, issue.1, pp.192-200, 2012. ,
DOI : 10.1002/hep.21503
Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3, Journal of Hepatology, vol.67, issue.4, pp.708-723, 2017. ,
DOI : 10.1016/j.jhep.2017.06.009
URL : https://hal.archives-ouvertes.fr/hal-01760472
Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease, Journal of Hepatology, vol.67, issue.3, pp.517-542, 2017. ,
DOI : 10.1016/j.jhep.2017.04.022
Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis, Annals of Intensive Care, vol.315, issue.424, p.33, 2017. ,
DOI : 10.1001/jama.2016.0288
URL : https://hal.archives-ouvertes.fr/hal-01519870
The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis, The American Journal of Gastroenterology, vol.5, issue.2, pp.235-277, 2018. ,
DOI : 10.1177/0898264312438551
Challenges to Liver Transplantation and Strategies to Improve Outcomes, Gastroenterology, vol.148, issue.2, pp.307-330, 2015. ,
DOI : 10.1053/j.gastro.2014.08.045
Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an Intensive Care Unit, Journal of Hepatology, vol.56, issue.1, pp.95-102, 2012. ,
DOI : 10.1016/j.jhep.2011.06.024
Cirrhotic patients in the ICU, Current Opinion in Critical Care, vol.19, issue.2, pp.154-60, 2013. ,
DOI : 10.1097/MCC.0b013e32835f0c17
Outcome of patients with cirrhosis requiring mechanical ventilation in ICU, Journal of Hepatology, vol.60, issue.3, pp.570-578, 2014. ,
DOI : 10.1016/j.jhep.2013.11.012
New perspectives for preventing hepatitis C virus liver graft infection, The Lancet Infectious Diseases, vol.16, issue.6, pp.735-780, 2016. ,
DOI : 10.1016/S1473-3099(16)00120-1
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study, Journal of Hepatology, vol.65, issue.3, pp.524-555, 2016. ,
DOI : 10.1016/j.jhep.2016.05.010
URL : https://hal.archives-ouvertes.fr/hal-01868079
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial, The Lancet Infectious Diseases, vol.16, issue.6, pp.685-97, 2016. ,
DOI : 10.1016/S1473-3099(16)00052-9
Personalized Adapted Physical Activity Before Liver Transplantation, Transplantation, vol.99, issue.1, pp.145-50, 2015. ,
DOI : 10.1097/TP.0000000000000245
Liver Transplantation for Hepatocellular Carcinoma: A Model Including ??-Fetoprotein Improves the Performance of Milan Criteria, Gastroenterology, vol.143, issue.4, pp.986-94, 2012. ,
DOI : 10.1053/j.gastro.2012.05.052
URL : https://hal.archives-ouvertes.fr/inserm-00865368
Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor, American Journal of Transplantation, vol.6, issue.2 Suppl 1, pp.129-166, 2010. ,
DOI : 10.1111/j.1600-6143.2006.01509.x
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis, New England Journal of Medicine, vol.334, issue.11, pp.693-702, 1996. ,
DOI : 10.1056/NEJM199603143341104
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival, Hepatology, vol.33, issue.6, pp.1394-403, 2001. ,
DOI : 10.1053/jhep.2001.24563
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis, The Lancet Oncology, vol.10, issue.1, pp.35-43, 2009. ,
DOI : 10.1016/S1470-2045(08)70284-5
The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition, Journal of Hepatology, vol.69, issue.1, 2018. ,
DOI : 10.1016/j.jhep.2018.02.012
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States, Gastroenterology, vol.148, issue.3, pp.547-55, 2015. ,
DOI : 10.1053/j.gastro.2014.11.039